Here, we demonstrate that combining Cpt1a inhibition with either the ketogenic diet, rich in LCFAs, or an anti-ErbB2 mAb reduces tumor growth, prolongs survival and enhances anti-tumor immune infiltration. The gene discussed is CPT1A; the disease is neoplasm.